Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q2 2025 ▲▼ | Q3 2025 ▲▼ | Change ▲▼ | Q2 2025 ▲▼ | Q3 2025 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Newamsterdam Pharma Company ORDINARY SHARES | 10,632,113 | 9,212,384 | -1,419,729 | $192.55M | $262.00M | 52.36% | +$69.45M |
| Dyne Therapeutics, Inc.(DYN) | 5,462,846 | 5,462,846 | 0 | $52.01M | $69.11M | 13.81% | +$17.10M |
| Engene Holdings Inc COM | 9,632,561 | 9,632,561 | 0 | $35.06M | $65.79M | 13.15% | +$30.73M |
| Astria Therapeutics Inc | 4,107,537 | 4,107,537 | 0 | $23.41M | $29.90M | 5.98% | +$6.49M |
| Bicycle Therapeutics PlcADS | 3,452,330 | 3,452,330 | 0 | $23.99M | $26.72M | 5.34% | +$2.73M |
| Vor Biopharma Inc.(VOR) | 0 | 379,640 | +379,640 | $0 | $18.50M | 3.70% | +$18.50M |
| Replimune Group, Inc.(REPL) | 3,909,696 | 4,158,368 | +248,672 | $36.32M | $17.42M | 3.48% | -$18.90M |
| Rapt Therapeutics Inc | 440,176 | 344,237 | -95,939 | $3.45M | $8.88M | 1.77% | +$5.43M |
| Engene Holdings IncW EXP 10 31 2028 *W EXP 10/31/202 | 2,878,148 | 2,878,148 | 0 | $2.36M | $2.07M | 0.41% | -$287.8K |